The effect of continuous glucose monitoring on glycaemic control in patients undergoing major surgery
Completed
- Conditions
- glucose monitoringsensor10018424
- Registration Number
- NL-OMON40722
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 36
Inclusion Criteria
- Aged 18-85
- Diagnosed with diabetes mellitus
- Able to give written informed consent
- Planned for laparotomy or cardiac surgery
- Will receive arterial line for standard patient care
- Planned postoperative stay at PACU or ICU
Exclusion Criteria
- Any condition that the local investigator feels would interfere with trial participation or the evaluation of results
- Allergy for heparin
- Known heparin induced thrombocytopenia
- Planned total panceatectomy
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcome measure is the difference in median glucose 1 hour after<br /><br>surgery, as a measure of glycaemic control during surgery.<br /><br>Furthermore, the time spent in the target range, time spent above the target<br /><br>range and time spent below the target range will be calculated. </p><br>
- Secondary Outcome Measures
Name Time Method